Indeed, drebrin-mediated synapse loss is at the center of other pathological disease states marked by spine loss28,29, such as Alzheimer’s disease, for which the marked decrease in drebrin expression has become a hallmark48. This evidence concerns the gene DBN1 and early-onset autosomal dominant Alzheimer disease.